Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (21)
- Safety monitoring and information (10)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
113 result(s) found, displaying 1 to 10
-
PageInformation and updates about the shortages of cyclophosphamide and ifosfamide injections.
-
PagePharmaceutical companies Novo Nordisk and Eli Lilly are gradually discontinuing some of their earlier generation insulin products. Our webpage lists affected products and includes alternative options.
-
GuidanceGuidance on the process for registering new medicines with new trade names that are 'clones' of currently registered prescription medicines
-
PageKey information and updates about the shortage of Creon (pancreatic extract) capsules.
-
-
PageInformation about progressive discontinuation of Benpen injection products
-
-
PageFind out about the shortage of Pegasys (peginterferon alfa-2a) injection.
-
PageInformation about what to include in the Product Information (PI) and Consumer Medicine Information (CMI) for products included in the Black Triangle Scheme.
-
PageInformation for applicants on requesting and preparing for pre-submission meetings for medicines and biologicals.